{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:14:05Z","timestamp":1760660045408,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jclinane.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T16:13:52Z","timestamp":1418314432000},"page":"247-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsy"],"prefix":"10.1016","volume":"27","author":[{"given":"Kelly J.","family":"Larson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica D.","family":"Wittwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne T.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby N.","family":"Weingarten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinane.2014.11.002_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"Q J Med"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12028-009-9206-z","article-title":"Methylene blue-associated serotonin syndrome: a \u201cgreen\u201d encephalopathy after parathyroidectomy","volume":"11","author":"Rowley","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1177\/0269881109105450","article-title":"Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium","volume":"24","author":"Stanford","year":"2010","journal-title":"J Psychopharmacol"},{"year":"2011","series-title":"FDA drug safety communication: serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications","author":"Food and Drug Administration","key":"10.1016\/j.jclinane.2014.11.002_bb0020"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1213\/01.ANE.0000134860.73875.CF","article-title":"Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy","volume":"99","author":"Bach","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/jnnp.2009.172221","article-title":"Serotonin syndrome following methylene blue infusion: a rare complication of antidepressant therapy","volume":"81","author":"Heritier Barras","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.otohns.2006.05.026","article-title":"Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization","volume":"135","author":"Kartha","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0040","doi-asserted-by":"crossref","first-page":"W9","DOI":"10.1308\/147870807X160434","article-title":"Prolonged postoperative altered mental status after methylene blue infusion during parathyroidectomy: a case report and review of the literature","volume":"89","author":"Khan","year":"2007","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5694\/j.1326-5377.2008.tb02168.x","article-title":"Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue","volume":"189","author":"Khavandi","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0022215105005098","article-title":"Methylene blue toxicity following infusion to localize parathyroid adenoma","volume":"120","author":"Majithia","year":"2006","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0055","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2044.2003.03415_23.x","article-title":"Neurological sequelae following methylene blue injection for parathyroidectomy","volume":"58","author":"Martindale","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03021907","article-title":"Dose-response and postoperative confusion following methylene blue infusion during parathyroidectomy","volume":"54","author":"Mihai","year":"2007","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0033-3182(10)70685-X","article-title":"The role of methylene blue in serotonin syndrome: a systematic review","volume":"51","author":"Ng","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hed.20416","article-title":"Adverse neurologic effect of methylene blue used during parathyroidectomy","volume":"28","author":"Patel","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/lary.20581","article-title":"Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use","volume":"119","author":"Pollack","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0080","first-page":"215","article-title":"Methylene blue encephalopathy: a case report and review of published cases","volume":"81","author":"Shopes","year":"2013","journal-title":"AANA J"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jamcollsurg.2006.12.030","article-title":"Methylene-blue-associated encephalopathy","volume":"204","author":"Sweet","year":"2007","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0090","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2044.2006.04619.x","article-title":"Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy","volume":"61","author":"Mathew","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0269881109359098","article-title":"CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity","volume":"25","author":"Gillman","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinane.2012.05.002","article-title":"Serotonin syndrome manifesting as patient movement during total intravenous anesthesia with propofol and remifentanil","volume":"25","author":"Davis","year":"2013","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jemermed.2008.01.003","article-title":"Serotonin syndrome precipitated by fentanyl during procedural sedation","volume":"38","author":"Kirschner","year":"2010","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0026-895X(24)12048-2","article-title":"(r)-, (s)-, and racemic fluoxetine n-demethylation by human cytochrome p450 enzymes","volume":"28","author":"Margolis","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-3565(24)29631-2","article-title":"Identification of the human cytochromes P450 responsible for in vitro formation of r- and s-norfluoxetine","volume":"297","author":"Ring","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl. 5","key":"10.1016\/j.jclinane.2014.11.002_bb0125","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/00004850-199809005-00009","article-title":"Differences in interactions of SSRIS","volume":"13","author":"Brosen","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0135","first-page":"470","article-title":"Pharmacokinetics of ssri antidepressants: half-life and clinical applicability","volume":"25","author":"Gury","year":"1999","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0140","series-title":"Medscape Drug Reference","article-title":"Selective serotonin reuptake inhibitors and CYP2D6","author":"Torkamani","year":"2014"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","article-title":"Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome p450 activities","volume":"32","author":"Li","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1078\/0944-7113-00379","article-title":"An approach to the in vitro evaluation of potential for cytochrome p450 enzyme inhibition from herbals and other natural remedies","volume":"11","author":"Strandell","year":"2004","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0155","first-page":"205","article-title":"Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features","volume":"2","author":"Marken","year":"2000","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.jclinane.2014.11.002_bb0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/00000542-200306000-00033","article-title":"Probable meperidine-induced serotonin syndrome in a patient with a history of fluoxetine use","volume":"98","author":"Tissot","year":"2003","journal-title":"Anesthesiology"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818014003699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818014003699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:03:37Z","timestamp":1760605417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818014003699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0952818014003699"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2014.11.002","relation":{},"ISSN":["0952-8180"],"issn-type":[{"type":"print","value":"0952-8180"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}